These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20467357)

  • 1. Another once-daily formulation of tramadol (Ryzolt).
    Med Lett Drugs Ther; 2010 May; 52(1338):39-40. PubMed ID: 20467357
    [No Abstract]   [Full Text] [Related]  

  • 2. Tramadol oral solution (Qdolo) for pain.
    Med Lett Drugs Ther; 2021 May; 63(1625):83-84. PubMed ID: 34101718
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.
    de Moraes NV; Lauretti GR; Coelho EB; Godoy AL; Neves DV; Lanchote VL
    Fundam Clin Pharmacol; 2016 Apr; 30(2):153-61. PubMed ID: 26947771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults: profile report.
    Hair PI; Curran MP; Keam SJ
    CNS Drugs; 2007; 21(3):259-63. PubMed ID: 17338595
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
    Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
    Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
    Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
    Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain.
    Klotz U
    Arzneimittelforschung; 2003; 53(10):681-7. PubMed ID: 14650359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Dose Pharmacokinetic Study of Tramadol Extended-Release Tablets in Children and Adolescents.
    Vandenbossche J; Van Peer A; Richards H
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):343-53. PubMed ID: 27138295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
    Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R
    Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tramadol sustained-release capsules.
    Keating GM
    Drugs; 2006; 66(2):223-30. PubMed ID: 16451094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
    Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tramadol sustained-release capsules : a viewpoint by Maurizio Evangelista.
    Evangelista M
    Drugs; 2006; 66(2):231-2. PubMed ID: 16451095
    [No Abstract]   [Full Text] [Related]  

  • 14. Tramadol sustained-release capsules: a viewpoint by Miquel Casals.
    Casals M
    Drugs; 2006; 66(2):231-3. PubMed ID: 16451096
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic dizziness in a pain patient--pharmacogenomic identification of tramadol as cause].
    Eichhorn A; Barth J
    Rehabilitation (Stuttg); 2010 Dec; 49(6):393-5. PubMed ID: 21140323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tramadol sustained-release capsules : a viewpoint by Sergio Canavero and Vincenzo Bonicalzi.
    Canavero S; Bonicalzi V
    Drugs; 2006; 66(2):232-3. PubMed ID: 16451097
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in Tramadol: Pharmacology, Metabolism, and Misuse.
    Miotto K; Cho AK; Khalil MA; Blanco K; Sasaki JD; Rawson R
    Anesth Analg; 2017 Jan; 124(1):44-51. PubMed ID: 27861439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tramadol extended-release tablets.
    Hair PI; Curran MP; Keam SJ
    Drugs; 2006; 66(15):2017-27; discussion 2028-30. PubMed ID: 17100415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects and assays of controlled-release tramadol and o-desmethyltramadol in cancer patients with pain.
    Leppert W; Mikolajczak P
    Curr Pharm Biotechnol; 2011 Feb; 12(2):306-12. PubMed ID: 21050160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
    Barkin RL
    Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.